Q86W47 (KCMB4_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
April 3, 2013.
Version 82.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Calcium-activated potassium channel subunit beta-4 Alternative name(s): BK channel subunit beta-4 Short name=BKbeta4 Short name=Hbeta4 Calcium-activated potassium channel, subfamily M subunit beta-4 Charybdotoxin receptor subunit beta-4 K(VCA)beta-4 Maxi K channel subunit beta-4 Slo-beta-4 | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) [Reference proteome] | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 210 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Regulatory subunit of the calcium activated potassium KCNMA1 (maxiK) channel. Modulates the calcium sensitivity and gating kinetics of KCNMA1, thereby contributing to KCNMA1 channel diversity. Decreases the gating kinetics and calcium sensitivity of the KCNMA1 channel, but with fast deactivation kinetics. May decrease KCNMA1 channel openings at low calcium concentrations but increases channel openings at high calcium concentrations. Makes KCNMA1 channel resistant to 100 nM charybdotoxin (CTX) toxin concentrations. Ref.1 Ref.2 Ref.3 |
| Subunit structure | Interacts with KCNMA1 tetramer. There are probably 4 molecules of KCMNB4 per KCNMA1 tetramer. Ref.3 Ref.4 |
| Subcellular location | |
| Tissue specificity | Predominantly expressed in brain. In brain, it is expressed in the cerebellum, cerebral cortex, medulla, spinal cord, occipital pole, frontal lobe, temporal lobe, putamen, amygdala, caudate nucleus, corpus callosum, hippocampus, substantia nigra and thalamus. Weakly or not expressed in other tissues. Ref.2 Ref.3 |
| Domain | Resistance to charybdotoxin (CTX) toxin is mediated by the extracellular domain. |
| Post-translational modification | Phosphorylated. Phosphorylation modulates its effect on KCNMA1 activation kinetics. Ref.6 N-glycosylated. A highly glycosylated form is promoted by KCNMA1. Glycosylation, which is not required for the interaction with KCNMA1 and subcellular location, increases protection against charybdotoxin. Ref.1 Ref.7 |
| Miscellaneous | Treatment with okadaic acid reduces its effect on KCNMA1. |
| Sequence similarities | Belongs to the KCNMB (TC 8.A.14.1) family. KCNMB4 subfamily. [View classification] |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 210 | 210 | Calcium-activated potassium channel subunit beta-4 | PRO_0000187055 | |||||
Regions | |||||||||
| Topological domain | 1 – 19 | 19 | Cytoplasmic Potential | ||||||
| Transmembrane | 20 – 40 | 21 | Helical; Name=1; Potential | ||||||
| Topological domain | 41 – 167 | 127 | Extracellular Potential | ||||||
| Transmembrane | 168 – 188 | 21 | Helical; Name=2; Potential | ||||||
| Topological domain | 189 – 210 | 22 | Cytoplasmic Potential | ||||||
Amino acid modifications | |||||||||
| Glycosylation | 53 | 1 | N-linked (GlcNAc...) | ||||||
| Glycosylation | 90 | 1 | N-linked (GlcNAc...) | ||||||
Natural variations | |||||||||
| Natural variant | 199 | 1 | V → I. Ref.1 | VAR_018178 | |||||
Experimental info | |||||||||
| Mutagenesis | 11 | 1 | T → A: Suppresses the effect of okadaic acid and increases activation time constant; when associated with A-17 and A-210. Ref.6 | ||||||
| Mutagenesis | 11 | 1 | T → D: Suppresses its effect on KCNMA1 channel activation and on deactivation kinetics; when associated with E-17 and E-210. Ref.6 | ||||||
| Mutagenesis | 17 | 1 | S → A: Suppresses the effect of okadaic acid and increases activation time constant; when associated with A-11 and A-210. Ref.6 | ||||||
| Mutagenesis | 17 | 1 | S → E: Suppresses its effect on KCNMA1 channel activation and on deactivation kinetics; when associated with D-11 and E-210. Ref.6 | ||||||
| Mutagenesis | 53 | 1 | N → A: Loss of N-glycosylation and reduced protection against charybdotoxin; when associated with A-90. Ref.7 | ||||||
| Mutagenesis | 90 | 1 | N → A: Loss of N-glycosylation and reduced protection against charybdotoxin; when associated with A-53. Ref.7 | ||||||
| Mutagenesis | 210 | 1 | S → A: Suppresses the effect of okadaic acid and increases activation time constant; when associated with A-11 and A-17. Ref.6 | ||||||
| Mutagenesis | 210 | 1 | S → E: Suppresses its effect on KCNMA1 channel activation and on deactivation kinetics; when associated with D-11 and E-17. Ref.6 | ||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "A neuronal beta subunit (KCNMB4) makes the large conductance, voltage- and Ca2+-activated K+ channel resistant to charybdotoxin and iberiotoxin." Meera P., Wallner M., Toro L. Proc. Natl. Acad. Sci. U.S.A. 97:5562-5567(2000) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, GLYCOSYLATION, VARIANT ILE-199. |
| [2] | "hKCNMB3 and hKCNMB4, cloning and characterization of two members of the large-conductance calcium-activated potassium channel beta subunit family." Behrens R., Nolting A., Reimann F., Schwarz M., Waldschuetz R., Pongs O. FEBS Lett. 474:99-106(2000) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY. |
| [3] | "Cloning and functional characterization of novel large conductance calcium-activated potassium channel beta subunits, hKCNMB3 and hKCNMB4." Brenner R., Jegla T.J., Wickenden A., Liu Y., Aldrich R.W. J. Biol. Chem. 275:6453-6461(2000) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, INTERACTION WITH KCNMA1, TISSUE SPECIFICITY. |
| [4] | "A novel nervous system beta subunit that downregulates human large conductance calcium-dependent potassium channels." Weiger T.M., Holmqvist M.H., Levitan I.B., Clark F.T., Sprague S., Huang W.-J., Ge P., Wang C., Lawson D., Jurman M.E., Glucksmann M.A., Silos-Santiago I., DiStefano P.S., Curtis R. J. Neurosci. 20:3563-3570(2000) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], INTERACTION WITH KCNMA1. Tissue: CNS. |
| [5] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Eye and Lymph. |
| [6] | "Phosphorylation-dependent functional coupling of hSlo calcium-dependent potassium channel and its hbeta 4 subunit." Jin P., Weiger T.M., Wu Y., Levitan I.B. J. Biol. Chem. 277:10014-10020(2002) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION, MUTAGENESIS OF THR-11; SER-17 AND SER-210. |
| [7] | "Reciprocal modulation between the alpha and beta 4 subunits of hSlo calcium-dependent potassium channels." Jin P., Weiger T.M., Levitan I.B. J. Biol. Chem. 277:43724-43729(2002) [PubMed] [Europe PMC] [Abstract] Cited for: GLYCOSYLATION, MUTAGENESIS OF ASN-53 AND ASN-90. |
| [8] | "New disguises for an old channel: MaxiK channel beta-subunits." Orio P., Rojas P., Ferreira G., Latorre R. News Physiol. Sci. 17:156-161(2002) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AF160967 mRNA. Translation: AAF69805.1. AF170917 mRNA. Translation: AAF89699.1. AF207992 mRNA. Translation: AAF28333.1. AF215891 mRNA. Translation: AAF75596.1. BC042446 mRNA. Translation: AAH42446.2. BC050621 mRNA. Translation: AAH50621.2. |
| IPI | IPI00217101. |
| RefSeq | NP_055320.4. NM_014505.5. |
| UniGene | Hs.525529. |
3D structure databases | |
| ProteinModelPortal | Q86W47. |
| ModBase | Search... |
Protein-protein interaction databases | |
| STRING | 9606.ENSP00000258111. |
PTM databases | |
| PhosphoSite | Q86W47. |
Polymorphism databases | |
| DMDM | 46395791. |
Proteomic databases | |
| PaxDb | Q86W47. |
| PRIDE | Q86W47. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000258111; ENSP00000258111; ENSG00000135643. |
| GeneID | 27345. |
| KEGG | hsa:27345. |
| UCSC | uc001svx.3. human. |
Organism-specific databases | |
| CTD | 27345. |
| GeneCards | GC12P070760. |
| HGNC | HGNC:6289. KCNMB4. |
| MIM | 605223. gene. |
| neXtProt | NX_Q86W47. |
| PharmGKB | PA30069. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | NOG83271. |
| HOGENOM | HOG000113205. |
| HOVERGEN | HBG052224. |
| InParanoid | Q86W47. |
| KO | K04941. |
| OMA | CFLWPVV. |
| OrthoDB | EOG4FBHTX. |
| PhylomeDB | Q86W47. |
Enzyme and pathway databases | |
| Reactome | REACT_13685. Neuronal System. REACT_604. Hemostasis. |
Gene expression databases | |
| Bgee | Q86W47. |
| CleanEx | HS_KCNMB4. |
| Genevestigator | Q86W47. |
| GermOnline | ENSG00000135643. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR003930. K_chnl_Ca-activ_BK_bsu. [Graphical view] |
| PANTHER | PTHR10258. PTHR10258. 1 hit. |
| Pfam | PF03185. CaKB. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| ChiTaRS | KCNMB4. human. |
| GenomeRNAi | 27345. |
| NextBio | 50430. |
| SOURCE | Search... |
Entry information
| Entry name | KCMB4_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q86W47 Secondary accession number(s): Q8IVR3, Q9NPA4, Q9P0G5 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 12 Human chromosome 12: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
